Drug Profile
Indium 111 ABT 806
Alternative Names: 111In-ABT-806; ABT-806iLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antineoplastics; Radiopharmaceutical diagnostics
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours(Diagnosis) in Australia (IV, Infusion)
- 31 Oct 2011 Phase-I clinical trials in Solid tumours in Australia (IV)